Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study by Kelly Fellows Maxwell (6852752)

“…</p><p>Results</p><p>FSS scores decreased from a baseline of 5.51 (95% CI: 4.86, 6.16) to a mean of 3.03 (95% CI: 2.23, 3.82) at 12 months (p < 0.001). …”

Analysis of sphingosine levels from BAL. by Henning Carstens (13132801)

ROS induction by free <i>versus</i> PLGA-adsorbed benzo(a)pyrene. by Rodolphe Carpentier (4357222)

Average annual change, 95% confidence interval and significance for sum concentrations of different compound groups. by Matti Viluksela (321291)

Increasing glucose (D-Glu) concentrations decreases TNF-mediated A20 protein up-regulation without affecting its transcriptional activation in SMC. by Gautam V. Shrikhande (227350)

Salience of authority-virtue phrases by year. by Daniel Hart (440152)

Thrombin generation in cirrhosis patients and healthy subjects. by Romy M. W. Kremers (819412)

Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1) by Sven Marcel Schmitt (2565385)

“…Its replacement by an amino group led to decreased activity. Aliphatic and aliphatic–aromatic variations at position 5 and 6 revealed compounds with IC₅₀ values in high nanomolar range. …”

The contribution of height to DLCO, VA and KCO. by Eldar Priel (12810045)

Histogram of dorsum PROM divided into classifications and measured with an electrogoniometer. by Mark P. Wilhelm (9258177)

Prothrombin conversion in cirrhosis patients and healthy subjects. by Romy M. W. Kremers (819412)

Fig 6 - by Billy Tchounke (16965084)

Fig 6 - by Matti Viluksela (321291)

Risk of bias across 22 included studie. by Kuo-Chuan Hung (8587392)

“…Subgroup analysis showed that ketamine/esketamine’s preventive effect on 1-week PPD was consistent, regardless of administration timing, type of agents, or total dosage (<0.5 vs. ≥0.5 mg/kg). For the 4–6-week period, PPD risk was favorably reduced only with postoperative administration or the use of esketamine, with the total dosage having no observed influence. …”

An overview of the selection process for studies. by Kuo-Chuan Hung (8587392)

“…Subgroup analysis showed that ketamine/esketamine’s preventive effect on 1-week PPD was consistent, regardless of administration timing, type of agents, or total dosage (<0.5 vs. ≥0.5 mg/kg). For the 4–6-week period, PPD risk was favorably reduced only with postoperative administration or the use of esketamine, with the total dosage having no observed influence. …”

Characteristics of studies (<i>n</i> = 22). by Kuo-Chuan Hung (8587392)

“…Subgroup analysis showed that ketamine/esketamine’s preventive effect on 1-week PPD was consistent, regardless of administration timing, type of agents, or total dosage (<0.5 vs. ≥0.5 mg/kg). For the 4–6-week period, PPD risk was favorably reduced only with postoperative administration or the use of esketamine, with the total dosage having no observed influence. …”

<i>Hpa</i> HaRxLs can promote or decrease <i>Pst</i>-LUX growth in different <i>Arabidopsis</i> accessions. by Georgina Fabro (198543)

Scatter plot of STJ Stiffness (ΔTU) and dorsum PROM (degrees) values. by Mark P. Wilhelm (9258177)

Shell colour luminance variation of five phenotypic groups according to background colour categories of <i>Polymita picta</i>. by Mario Juan Gordillo-Pérez (20565248)

Fig 4 - by Fatemeh Mirzapour-Shafiyi (10981427)